pAG-DddA Fusion DNA Cytosine Deaminase
Research
Online Inquiry

pAG-DddA Fusion DNA Cytosine Deaminase

Cat.No: IEC-HMM-0113 Datasheet

Quantities:
- +
Product Details Related Products
Product Name pAG-DddA Fusion DNA Cytosine Deaminase
Catalog No. IEC-HMM-0113
Description An engineered Protein A/G–DddA fusion enzyme for antibody-directed deamination of exposed double-stranded DNA in epigenetic footprinting assays.
Intended Use Transcription factor footprinting, targeted chromatin analysis and epigenetic method development.
Principle / Technology The Protein A/G domain binds an antibody localized to a chromatin target, while the DddA domain converts accessible cytosines in nearby double-stranded DNA to uracil.
Detection Method Sequencing-based cytosine-conversion and footprint analysis.
Sample Type Antibody-labeled chromatin or nuclei prepared for deaminase-based epigenetic assays.
Performance Range / Specifications 20 µg or 80 µg packages.
Specificity Antibody-mediated localization concentrates deaminase activity near the selected chromatin-associated protein.
Reaction Conditions / Protocol Bind a validated primary antibody to the chromatin target, recruit the fusion enzyme, perform controlled deamination, and proceed with library preparation and sequencing.
Components / Formulation Purified Protein A/G–DddA fusion enzyme solution.
Storage Conditions Store at −30 to −15°C.
Package Specifications 20 µg; 80 µg.
Product Form Purified fusion enzyme solution.
Key Features Antibody-directed localization; efficient double-stranded DNA cytosine deamination; simplified footprinting workflow.
Shipping Conditions Ship at or below 0°C.
Compatibility Suitable for deaminase-based targeted chromatin and transcription factor footprinting protocols.
Application Notes / Precautions Use a validated antibody and optimize enzyme exposure to balance conversion efficiency and spatial resolution.

For research use only, not for clinical use.

0
0

There is no product in your cart.